Ariol SL-50 Workstation and Review Stations
Ariol SL-50 工作站和检查站
基本信息
- 批准号:6877240
- 负责人:
- 金额:$ 33.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-04-01 至 2006-03-31
- 项目状态:已结题
- 来源:
- 关键词:biomedical automationbiomedical equipment purchasebiomedical resourceclinical chemistrycomputer data analysiscomputer networkcomputer program /softwarecytodiagnosisdiagnosis quality /standardexfoliative cytologyfluorescent dye /probefluorescent in situ hybridizationimmunocytochemistrymolecular /cellular imaging
项目摘要
Investigation of biomarkers of pre-neoplasia as well as markers for prognosis and response to
individualized therapies is increasingly important in translational research, a major focus of Vanderbilt University School of Medicine. One recent advance relevant to these translational efforts is the development of tissue microarrays (TMAs), which allow high through-put analysis of expression of numerous markers as determined by immunohistochemistry and immunofluorescence. However, the utility of TMAs is limited by the subjective semi-quantitative nature of the data analysis by individual pathologists. We are requesting funds to purchase an Ariol SL-50 Automated Cellular Scanning Quantitation System to overcome these limitations. This system will obtain digitized images of stained slides at various magnifications, including
different types of stains, counterstains, immunohistochemical chromagens, and multiple fluorescent probes. Because the Ariol SL-50 system is automated and can scan in 50 slides overnight, facilitation of analysis of multiple slides without human intervention is possible. The images are easily reviewable by a consulting pathologist to confmn the veracity of interpretation. The most important characteristic of the system is the ability to quantify staining using varying calculations including the area of staining as a percent of total tissue area, staining per cell and number of stained cells and to differentiate patterns of intracellular staining among nuclear, cytoplasmic and plasma membrane locations. Operation of the instrument will be supervised by Dr. Washington, who will also oversee maintenance. Service contract fees will be offset by charging a small user fee per slide. Major users are primarily investigators from the VUMC Lung, GI, and Breast SPOREs, the Skin Diseases Research Center, and the Digestive Diseases Research Center. Use of the system and prioritization of access will be under the oversight of the Utilization Committee. The presence of this instrument will allow us to embark on the large-scale translational biomarker studies that are required for evaluation of diagnostic and prognostic markers. An additional benefit is the ease of data sharing among groups, facilitating interactions among investigators and promoting inter-SPORE collaborations.
肿瘤前病变的生物标志物及其预后和疗效的研究
个体化治疗在转化研究中越来越重要,这是范德比尔特大学医学院的一个主要关注点。与这些翻译工作相关的一个最新进展是组织微阵列(TMA)的发展,它允许高通量分析通过免疫组织化学和免疫荧光确定的许多标记物的表达。然而,TMAS的实用性受到个体病理学家数据分析的主观半定量性质的限制。我们正在申请资金购买Ariol SL-50自动细胞扫描定量系统,以克服这些限制。该系统将获得不同放大倍数的染色幻灯片的数字化图像,包括
不同类型的染色,反染色,免疫组织化学染色和多种荧光探针。由于Ariol SL-50系统是自动化的,可以连夜扫描50张幻灯片,因此可以在没有人工干预的情况下简化多张幻灯片的分析。咨询病理学家可以很容易地查看这些图像,以混淆解释的真实性。该系统最重要的特点是能够使用不同的计算方法对染色进行量化,包括染色面积占总组织面积的百分比、每个细胞的染色和染色细胞的数量,以及区分细胞核、细胞质和质膜位置的细胞内染色模式。该仪器的操作将由华盛顿博士监督,他还将监督维护工作。服务合同费将通过向每张幻灯片收取少量使用费来抵消。主要用户是来自VUMC肺、胃和乳房孢子、皮肤病研究中心和消化系统疾病研究中心的研究人员。该系统的使用和准入的优先次序将由利用委员会监督。这一仪器的出现将使我们能够开始大规模的生物标记物翻译研究,这是评估诊断和预后标记物所必需的。另一个好处是便于小组之间的数据共享,促进调查人员之间的互动和促进孢子间的合作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARY Kay WASHINGTON其他文献
MARY Kay WASHINGTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARY Kay WASHINGTON', 18)}}的其他基金
Core 1: Tissue Pathology and Cellular Analysis
核心 1:组织病理学和细胞分析
- 批准号:
10443608 - 财政年份:2019
- 资助金额:
$ 33.79万 - 项目类别:
Core 1: Tissue Pathology and Cellular Analysis
核心 1:组织病理学和细胞分析
- 批准号:
10218106 - 财政年份:2019
- 资助金额:
$ 33.79万 - 项目类别:
Core 1: Tissue Pathology and Cellular Analysis
核心 1:组织病理学和细胞分析
- 批准号:
10700840 - 财政年份:2019
- 资助金额:
$ 33.79万 - 项目类别:
Tennessee Valley Cooperative Human Tissue Network
田纳西谷合作人体组织网络
- 批准号:
9899210 - 财政年份:2014
- 资助金额:
$ 33.79万 - 项目类别:
Tennessee Valley Cooperative Human Tissue Network
田纳西谷合作人体组织网络
- 批准号:
10378774 - 财政年份:2014
- 资助金额:
$ 33.79万 - 项目类别:
Tennessee Valley Cooperative Human Tissue Network
田纳西谷合作人体组织网络
- 批准号:
10577781 - 财政年份:2014
- 资助金额:
$ 33.79万 - 项目类别:
Tennessee Valley Cooperative Human Tissue Network
田纳西谷合作人体组织网络
- 批准号:
9247707 - 财政年份:2014
- 资助金额:
$ 33.79万 - 项目类别:
Tennessee Valley Cooperative Human Tissue Network
田纳西谷合作人体组织网络
- 批准号:
8669436 - 财政年份:2014
- 资助金额:
$ 33.79万 - 项目类别: